Soligenix (SNGX) Stock: Buy, Sell, or Hold?

SNGX - Soligenix, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.38
0.00 (-0.49%) â–ŧ
5d: +3.86%
30d: +0.08%
90d: -6.27%
WAIT
LOW Confidence
Analysis Updated: Sep 25, 2026 12:00 AM ET
Earnings: Nov 06, 2026

Get Alerted When SNGX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: SNGX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SNGX is currently trading at $0.38, which is considered fair relative to its 30-day fair value range of $0.37 to $0.39.

Technical Outlook: Technically, SNGX is showing sideways momentum. Immediate support is located at $0.35, while resistance sits at $0.40.

Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.38 (+257.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.37 - $0.39
Company Quality Score 46/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (43/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 257.8% below Wall St target ($1.38)
  • WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $0.37 - $0.39
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $0.36
Resistance Level $0.40
Current Trend Sideways
Technical data as of Sep 25, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.54
Wall Street Target $1.38 (+257.8%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 27, 2026 2:01 AM ET
Data refreshes hourly during market hours. Next update: 3:01 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SNGX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$433 48 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$200 54 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$88 50 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$110 48 HOLD
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$21 57 HOLD

More Analysis for SNGX

SNGX Technical Chart SNGX Price Prediction SNGX Earnings Date SNGX Investment Advisor SNGX Fair Price Analyzer SNGX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals